BIOMAT Database Logo BIOMAT Database Logo

Coulometric determination of S-carboxymethyl-L-cysteine. 1988

K I Nikolić, and K R Velasević, and M F Ruasse

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D002233 Carbocysteine A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action. 3-(Carboxymethylthio)alanine,Carbocysteine, L-Isomer,Mucodine,Mucodyne,Mukodin,Rhinathiol,S-(Carboxymethyl)-L-cysteine,S-Carboxymethylcysteine,Thiodril,Carbocysteine, L Isomer,L-Isomer Carbocysteine,S Carboxymethylcysteine
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries

Related Publications

K I Nikolić, and K R Velasević, and M F Ruasse
S-carboxymethyl-L-cysteine.
May 2012, Drug metabolism reviews,
K I Nikolić, and K R Velasević, and M F Ruasse
[Quantitative HPLC determination of S-carboxymethyl-L-cysteine in pharmaceutical dosage form].
March 1980, Bollettino chimico farmaceutico,
K I Nikolić, and K R Velasević, and M F Ruasse
Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine.
January 1988, Drug metabolism and drug interactions,
K I Nikolić, and K R Velasević, and M F Ruasse
S-Carboxymethyl-L-cysteine-induced Fixed Drug Eruption.
June 2019, Acta dermato-venereologica,
K I Nikolić, and K R Velasević, and M F Ruasse
The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine.
January 1989, Pharmacology & therapeutics,
K I Nikolić, and K R Velasević, and M F Ruasse
Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
October 1982, Biochemical pharmacology,
K I Nikolić, and K R Velasević, and M F Ruasse
The sulphoxidation of S-carboxymethyl-L-cysteine in COPD.
April 2006, The European respiratory journal,
K I Nikolić, and K R Velasević, and M F Ruasse
Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
September 1986, Biochemical pharmacology,
K I Nikolić, and K R Velasević, and M F Ruasse
Oxidation of S-carboxymethyl-L-cysteine by glutamate dehydrogenase.
January 1972, Physiological chemistry and physics,
K I Nikolić, and K R Velasević, and M F Ruasse
Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man.
January 2003, Drug metabolism and drug interactions,
Copied contents to your clipboard!